Previous Article | Next Article ![]()
Infection and Immunity, January 1999, p. 308-318, Vol. 67, No. 1
Department of
Immunology1 and
Department of
Parasitology,2 Instituto de Ciências
Biomédicas, Universidade de São Paulo, São Paulo,
SP, Brazil
Received 9 July 1998/Returned for modification 18 August
1998/Accepted 23 October 1998
To obtain low and high parasite loads in the acute phase of
Chagas' disease, A/J mice were infected with 103 or
105 Trypanosoma cruzi trypomastigotes of the Y
strain and treated on day 6 with benznidazol. One year later,
chronically infected mice were screened for subpatent parasitemias,
tissue pathology, and immune response. Mice infected with the high
parasite inoculum showed higher levels of chronic parasitemias, heart
and striated muscle inflammation, and activation of the immune system
than did mice infected with the low inoculum. Concerning the activation of the immune system, the main findings for high-dose-infected mice
were (i) increased numbers of splenocytes, with preferential expansion
of CD8+ and B220
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Influence of Acute-Phase Parasite Load on
Pathology, Parasitism, and Activation of the Immune System at the
Late Chronic Phase of Chagas' Disease
CD5
cells,
many of them bearing a macrophage phenotype; (ii) higher frequencies of
B (B220+), CD4+, and CD8+ large
lymphocytes; (iii) a shift of CD4+ cells towards a
CD45RBLow phenotype; (iv) increased frequencies of both
CD45RBLow and CD45RBHigh large CD4+
cells; (v) augmented numbers of total immunoglobulin (Ig)-secreting cells, with predominance of IgG2a-producing cells; and (vi) increased production of gamma interferon and interleukin 4. In addition, these
mice presented lower IgM and higher IgG2a and IgG1 parasite-specific serum antibody levels. Our results indicate that the parasite load at
the acute phase of T. cruzi infection influences the
activation of the immune system and development of Chagas' disease
pathology at the late chronic phase of the disease.
*
Corresponding author. Mailing address: Departamento de
Imunologia, ICB, Av. Prof. Lineu Prestes, 1730, Universidade de
São Paulo, São Paulo, SP, CEP-05508-900, Brazil. Phone:
(55) (11) 818 7389. Fax: (55) (11) 818 7224. E-mail:
jmamosig{at}biomed.icb2.usp.br.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|